蓝帆医疗
(002382)
| 流通市值：59.27亿 | | | 总市值：59.85亿 |
| 流通股本：9.98亿 | | | 总股本：10.08亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 3,705,296,598.46 | 1,624,785,065.65 | 5,739,692,552.6 | 4,181,728,803.56 |
| 营业总成本 | 3,353,237,069.26 | 1,574,843,236.35 | 6,183,340,015.79 | 4,540,279,927.07 |
| 其他经营收益 | | | | |
| 营业利润 | 331,969,472.85 | 59,861,667.82 | -572,983,707.02 | -345,907,748.29 |
| 利润总额 | 335,771,648.25 | 66,085,772.32 | -661,135,540.03 | -347,690,262.49 |
| 净利润 | 210,375,191.03 | 33,992,986.37 | -798,411,318.3 | -302,696,214.99 |
| 每股收益 | | | | |
| 其他综合收益 | -167,150,636.29 | -91,161,983.42 | -69,235,627.82 | -12,376,023.67 |
| 综合收益总额 | 43,224,554.74 | -57,168,997.05 | -867,646,946.12 | -315,072,238.66 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 4,528,845,672.89 | 5,079,883,068.04 | 5,506,306,228.85 | 5,162,220,796.66 |
| 非流动资产: | | | | |
| 非流动资产合计 | 10,938,940,282.32 | 11,036,561,550.38 | 11,255,990,983.23 | 11,292,916,792.29 |
| 资产总计 | 15,467,785,955.21 | 16,116,444,618.42 | 16,762,297,212.08 | 16,455,137,588.95 |
| 流动负债: | | | | |
| 流动负债合计 | 4,983,344,310.85 | 5,821,987,298.85 | 6,474,657,561.23 | 5,941,263,396.6 |
| 非流动负债: | | | | |
| 非流动负债合计 | 971,707,224.39 | 885,778,450.99 | 826,793,152.88 | 806,987,990.28 |
| 负债合计 | 5,955,051,535.24 | 6,707,765,749.84 | 7,301,450,714.11 | 6,748,251,386.88 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 7,129,943,031.63 | 7,094,506,787.21 | 7,165,017,133.63 | 7,893,580,049.9 |
| 股东权益合计 | 9,512,734,419.97 | 9,408,678,868.58 | 9,460,846,497.97 | 9,706,886,202.07 |
| 负债和股东权益合计 | 15,467,785,955.21 | 16,116,444,618.42 | 16,762,297,212.08 | 16,455,137,588.95 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 3,643,231,379.07 | 1,742,921,431.63 | 6,688,175,500.89 | 4,896,694,110.45 |
| 经营活动现金流出小计 | 3,222,622,326.99 | 1,670,684,901.2 | 6,230,452,253.31 | 4,669,417,935.55 |
| 经营活动产生的现金流量净额 | 420,609,052.08 | 72,236,530.43 | 457,723,247.58 | 227,276,174.9 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,617,236,245.39 | 1,752,115,281.13 | 120,529,491.84 | 1,642,215,942.63 |
| 投资活动现金流出小计 | 2,282,347,640.72 | 1,452,838,586.24 | 1,384,901,247.25 | 2,505,198,942.7 |
| 投资活动产生的现金流量净额 | 334,888,604.67 | 299,276,694.89 | -1,264,371,755.41 | -862,983,000.07 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,170,489,890.18 | 49,703,350.96 | 1,822,741,048.62 | 998,476,811.27 |
| 筹资活动现金流出小计 | 2,541,771,625.77 | 535,113,337.1 | 1,284,421,764.59 | 935,558,928.59 |
| 筹资活动产生的现金流量净额 | -1,371,281,735.59 | -485,409,986.14 | 538,319,284.03 | 62,917,882.68 |
| 汇率变动对现金及现金等价物的影响 | -25,157,385.81 | -19,411,755.37 | -2,604,335.33 | 16,287,696.05 |
| 现金及现金等价物净增加额 | -640,941,464.65 | -133,308,516.19 | -270,933,559.13 | -556,501,246.44 |
| 期末现金及现金等价物余额 | 982,105,123.82 | 1,489,738,072.28 | 1,623,046,588.47 | 1,265,523,681.04 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -640,941,464.65 | - | -270,933,559.13 | - |